In vitro regulation of pericellular proteolysis in prostatic tumor cells treated with bombesin

International Journal of Cancer

Volumn 75, Issue 3, 1998, Pages 418-431

  Festuccia, Claudio ^a   Guerra, Fulvio ^a   D'Ascenzo, Sandra ^a   Giunciuglio, Daniela ^b   Albini, Adriana ^b   Bologna, Mauro ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BOMBESIN; EPIDERMAL GROWTH FACTOR; TISSUE INHIBITOR OF METALLOPROTEINASE; UROKINASE;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION;

EID: 0032579232     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980130)75:3<418::AID-IJC16>3.0.CO;2-4     Document Type: Article

References (29)

1. ABRAHAMSSON, P.-A., Neuro-endocrine differentiation and hormone-refractory prostate cancer. Prostate, 6, 3-8 (1996).
2. ALBINI, A., IWAMOTO, Y., MARTIN, G.R., AARONSON, S., KOZLOWSKI, J.M. and MCEWAN, R.N., A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res., 47, 3239-3245 (1987).
3. ANDREASEN, P.A., NIELSEN, L.S., KRISTIANSEN, P., GRØNDAHL-HANSEN, J., SKRIVER, L. and DANØ, K., Plasminogen-activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its pro-enzyme. J. biol. Chem., 261, 7644-7651 (1986).
4. BEHRENDT, N., RØNNE, E., PLOUG, M., PETRI, T., LOBER, D., NIELSEN, L.S., SCHLEUNING, W.-D., BLASI, F., APPELLA, E. and DANØ, K., The human receptor for urokinase plasminogen activator. NH2-terminal sequence and glycosylation variants. J. biol. Chem., 265, 6453-6460 (1990).
5. BILLSTROM, A., HARTLEY-ASP, B., LECANDER, I., BATRA, S. and ASTEDT, B., The urokinase inhibitor p-aminobenzamidine inhibits growth of a human prostatic tumor in SCID mice. Int. J. Cancer, 61, 542-547 (1995).
6. BLASI, F., Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness. Bioassays, 15, 105-111 (1993).
7. BOLOGNA, M., FESTUCCIA, C., MUZI, P., BIORDI, L. and CIOMEI, M., Bombesin stimulates growth of human prostatic cancer cells in vitro. Cancer, 63, 1714-1720 (1989).
8. COHEN, R.J., GLEZERSON, G. and HAFFEJEE, Z., Neuro-endocrine cells: a new prognostic parameter in prostate cancer. Brit. J. Urol., 68, 258-262 (1991).
9. CROWLEY, C.W., COHEN, R.L., LUCAS, B.K., LIU, G., SHUMATO, M.A. and LEVINSON, A.D., Prevention of metastasis by inhibition of the urokinase receptor. Cell. Biol., 90, 5021-5025 (1993).
10. DI SANT' AGNESE, P.A. and COCKETT, A.T.K., The prostatic endocrineparacrine (neuro-endocrine) regulatory system and neuro-endocrine differentiation in prostatic carcinoma: a review and future directions in basic research. J. Urol., 152, 1927-1931 (1994).
11. FESTUCCIA, C., BOLOGNA, M., VICENTINI, C., TACCONELLI, A., MIANO, R., VIOLINI, S. and MACKAY, A.R., Increased matrix metalloproteinase-9 secretion in short-term tissue cultures of prostatic tumor cells. Int. J. Cancer. 69, 386-393 (1996).
12. FESTUCCIA, C., VICENTINI, C., FIRMA, N., DI PASQUALE, A.B., ACETO, G., ZAZZERONI, F., MIANO, L. and BOLOGNA, M., Plasminogen activator activities in short-term tissue cultures of benign prostatic hyperplasia and prostatic carcinoma. Oncol. Res., 7, 131-138 (1995).
13. HALL, S.W., HUNPHRIES, J.E. and GONIAS, S.L., Inhibition of cell-surface-receptor-bound plasmin by α2-antiplasmin and α2-macroglobulin. J. biol. Chem., 266, 12329-12336 (1991).
14. HAMDY, F.C., COTTAM, D.W., REES, R.C. and WILLIAMS, J.L., Matrix-metalloproteinase-9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia. Brit. J. Cancer, 69, 177-182 (1994).
15. HEINERT, G., KIRCHHEIMER, J.C., PFLUGER, H. and BINDER, B.R., Urokinase-type plasminogen activator as a marker for the formation of distant metastases in prostatic carcinomas. J. Urol., 140, 1466-1469 (1988).
16. HOOSEIN, N.M., LOGOTHETIS, C.J. and CHUNG, L.W.K., Differential effects of peptide hormones bombesin, vaso-intestinal polypeptide and somatosiatin analog RC-160 on the invasive capacity of human prostatic carcinoma cells. J. Urol., 149, 1209-1213 (1993).
17. JARRAD, D.F., BLITZ, B.F., SMITH, R.C., PATEI, B.L. and RUKSTELIS, D.B., Effect of EGF on prostate-cancer cell line PC3 growth and invasion. Prostate, 24, 46-53 (1994).
18. KLEINMAN, H.K., MCGARVEY, M.L., HASSEL, J.R., STAR, V.L., CANNON, F., LAURIE, G.W. and MARTIN, G.R., Basement-membrane complexes with biological activity. Biochemistry, 25, 312-318 (1988).
19. KOUTSILLIERIS, M., SOURLA, A., PELLETTIER, G. and DOILLON, C.J., Three-dimensional type-I collagen system for the study of osteoblastic metastases produced by metastatic prostate cancer. J. Bone Miner. Res., 9, 1823-1832 (1994).
20. LYON, P.B., SEE, W.A., XU, Y. and COHEN, M.B., Diversity and modulation of plasminogen activator activity in human prostate-carcinoma cell lines. Prostate, 27, 179-186 (1995).
21. NIELSEN, L.S., GRØNDAHL-HANSEN, J., ANDREASEN, P.A., SKRIVER, L., ZEUTHEN, J. and DANØ, K., Enzyme-linked immunosorbent assay for human urokinase-type plasminogen activators and its pro-enzyme using a combination of monoclonal and polyclonal antibodies. J. Immunoassay, 7, 209-228 (1986).
22. NOORDZIJ, M.A., VAN DER KWAST, T.H., VAN STEENBRUGGE, G.J., HOP, W.J.C. and SCHROEDER, F.H., The prognostic influence of neuro-endocrine cells in prostate cancer: results of a long-term follow-up study with patients treated by radical prostatectomy. Int. J. Cancer, 62, 252-258 (1995).
23. POLLANEN, J., EDMAN, K., NIELSEN, L.S., DANØ, K. and VAHERI, A., Ultrastructural localization of plasma-membrane-associated urokinase-type plasminogen activator of focal contacts. J. Cell Biol., 106, 87-95 (1988).
24. 125I-(Ty24)-bombesin by tumor cells. Prostate, 25, 29-38 (1994).
25. SCHMITT, M., JANICKE, F., MONIVA, N., CHUCHOLOWSKI, N., PACKE, L. and GRAEFF, H., Tumor-associated urokinase-type plasminogen activator: biological and clinical significance. Biol. Chem., 373, 611-622 (1992).
26. SHIMA, T., SASAGURI, Y., KUSUKAWA, J., NAKANO, R., YAMAN, H., FUJITA. H., KAKEGAWA, T. and MORIMATSU, M., Production of matrix metalloproteinase-9 (92-kD gelatinase) by human oesophageal squamous-cell carcinoma in response to epidermal growth factor. Brit. J. Cancer, 67, 721-727 (1993).
27. STEPHENS, R.W., POLLANEN, J., TAPIOVAARA, H., LEUNG, K.-C., SIM, P.-S., SALONEN, E.-M., RØNNE, E., BEHRENDT, N., DANØ, K. and VAHERI, A., Activation of pro-urokianse and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants. J. Cell Biol., 108, 1987-1995 (1989).
28. STOPPELLI, M.P., TACCHETTI, C., CUBELLIS, M.V., CORTI, A., HEARING, V.J., CASSANI, G., APPELLA, E. and BLASI, F., Autocrine saturation of prourokinase receptors on human A431 cells. Cell, 45, 675-684 (1986).
29. WUN, T.C. and REICH, E., An inhibitor of plasminogen activation from human placenta. J. biol. Chem., 262, 3646-3653 (1987).